Investigating Virus-Host Interplay in Human Primary Models of Genetically Modified Respiratory Epithelium

The InVIRium project aims to enhance understanding of respiratory viruses by using advanced human airway models to study antiviral defenses and viral escape mechanisms.

Subsidie
€ 2.475.808
2024

Projectdetails

Introduction

Respiratory viruses can rapidly spread worldwide with a devastating impact, as dramatically highlighted by the COVID-19 pandemic. In addition to the pandemic threat posed by influenza A viruses (IAV) or coronaviruses, respiratory viruses, including IAV, influenza B virus (IBV), seasonal coronaviruses, and respiratory syncytial virus (RSV), are the cause of yearly epidemics, with a huge impact on human health.

Current Research Limitations

The vast majority of in vitro studies have been performed with model cancer cell lines. However, they share limited features with the primary cells found within the human respiratory epithelium. Robust and relevant ex vivo models of human primary airway epithelia, cultured at the air-liquid interface (ALI), have been developed over the years and nicely recapitulate the structure and composition of the in vivo respiratory epithelium.

Knowledge Gap

Nevertheless, in-depth studies on the genes and the potent innate immune, interferon (IFN)-induced defenses regulating viral replication in such pertinent models are still lacking.

Project Overview

The InVIRium project will address this knowledge gap by combining a newly acquired expertise in the generation and gene editing of human ALI airway epithelia with a strong expertise in CRISPR screens and virology.

Objectives

The objectives of InVIRium will be to:

  1. Explore in depth the relationships between major human respiratory viruses: SARS-CoV-2, IAV, IBV, and RSV, and their relevant primary target cells.
  2. Characterize the IFN-stimulated genes responsible for the potent antiviral state.
  3. Explore the mechanisms of SARS-CoV-2 escape from the IFN system.
  4. Define the landscape of host genes regulating respiratory virus infection in this physiologically relevant ALI model.

Impact

InVIRium will bring a change of paradigm in the way we study respiratory viruses by implementing cutting-edge approaches in highly pertinent human models. It will gather fundamental knowledge that is currently lacking on the interactions between viruses and their primary target cells.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.475.808
Totale projectbegroting€ 2.475.808

Tijdlijn

Startdatum1-1-2024
Einddatum31-12-2028
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense

This project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases.

€ 1.500.000
ERC ADG

Traitor-virus-guided discovery of antiviral factors

This project aims to use CRISPR/Cas9 technology with HIV-1 to uncover antiviral mechanisms, enhancing our understanding and control of viral pathogens for better prevention and therapy.

€ 2.339.875
ERC STG

Outlining the Role of IgA in Memory Instruction

The ORIgAMI project aims to investigate the role of IgA+ B cells in respiratory infections to enhance vaccine design against airborne viruses like influenza and SARS-CoV-2.

€ 2.049.049
ERC POC

Virus Inhibition by siRNA Optimized by NMR

This project aims to develop a novel class of siRNA molecules targeting SARS-CoV-2 variants using structural biology, with potential applications for other pathogenic viruses.

€ 150.000